Common synthetic lethality partnersare BRCA1/2, which play a vital role in annealing RAD51 to ssDNA;however mutations in these proteins are quite common,161 and when this occurs, the cancer cell can compensateby utilizing RAD52 to perform the task instead. This evidence concerns the gene BRCA1 and cancer.